Neofect
Innovative home exercise device and software for stroke survivors' fast recovery and rehabilitation.
Launch date
Employees
Market cap
AUD50.1m
Enterprise valuation
AUD56m (Public information from Sep 2024)
Share price
KRW998 290660.KQ
Company register number 1198629663
San Francisco California (HQ)
Financials
Estimates*
KRW | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 4.5b | 5.7b | 12.3b | 18.6b | 23.2b | 26.2b | 26.6b |
% growth | - | 27 % | 118 % | 51 % | 24 % | 13 % | 2 % |
EBITDA | (3.7b) | (4.6b) | (11.8b) | (11.5b) | (4.5b) | (4.6b) | 411m |
% EBITDA margin | (83 %) | (82 %) | (96 %) | (62 %) | (20 %) | (18 %) | 2 % |
Profit | (4.4b) | (9.6b) | (15.8b) | (15.0b) | (5.0b) | (9.6b) | (5.0b) |
% profit margin | (99 %) | (170 %) | (129 %) | (81 %) | (22 %) | (37 %) | (19 %) |
EV / revenue | - | 12.5x | 6.0x | 4.0x | 3.4x | 2.0x | 2.2x |
EV / EBITDA | - | -15.3x | -6.2x | -6.6x | -17.2x | -11.6x | 143.2x |
R&D budget | - | - | - | 1.7b | 1.5b | 1.9b | 1.5b |
R&D % of revenue | - | - | - | 9 % | 6 % | 7 % | 6 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
* | KRW1.0b | Series A | |
* | KRW4.2b | Series B | |
KRW6.0b | Series B | ||
KRW6.0b | Series C | ||
N/A | N/A | IPO | |
N/A | N/A | Post IPO Equity | |
N/A | KRW35.5b | Post IPO Equity | |
Total Funding | AUD22.3m |
Related Content
Recent News about Neofect
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Neofect
EditACQUISITION by Neofect Jul 2019